Onyx shares rally after FDA OKs cancer treatment – MarketWatch
abc7news.com Onyx shares rally after FDA OKs cancer treatment MarketWatch LOS ANGELES (MarketWatch) — Shares of Onyx Pharmaceuticals Inc. (US:onxx) rallied 11% to $76.29 Friday afternoon after the US Food and Drug Administration approved the company’s Kyprolis for patients with multiple myeloma who have received at least ..
See original article:
Onyx shares rally after FDA OKs cancer treatment – MarketWatch
Short URL: http://www.directglobalmedia.com/?p=260958
Posted by
on Jul 21 2012. Filed under Healthcare News.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
